Selectis Health, Inc.
GBCS
$3.10
$0.134.38%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -30.50% | -6.98% | 8.22% | 10.80% | 12.37% |
| Total Revenue | -30.50% | -6.98% | 8.22% | 8.93% | 10.48% |
| Cost of Revenue | -24.91% | -10.99% | 12.49% | 9.98% | 7.73% |
| Gross Profit | -49.27% | 5.50% | -4.99% | 5.38% | 20.83% |
| SG&A Expenses | -12.78% | 18.38% | -30.47% | -5.95% | 8.87% |
| Depreciation & Amortization | -8.21% | 5.87% | -2.51% | -11.43% | -14.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.61% | -4.07% | -0.46% | 5.25% | 7.07% |
| Operating Income | -199.38% | -306.68% | 74.65% | 41.05% | 39.44% |
| Income Before Tax | 1,157.33% | -39.34% | 146.82% | -138.78% | 36.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,094.88% | -39.48% | 146.82% | -138.78% | 36.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,094.88% | -39.48% | 146.82% | -138.78% | 36.60% |
| EBIT | -199.38% | -306.68% | 74.65% | 41.05% | 39.44% |
| EBITDA | -1,483.13% | -104.41% | 108.49% | 75.31% | 78.47% |
| EPS Basic | 1,071.44% | -40.74% | 146.14% | -140.12% | 35.61% |
| Normalized Basic EPS | -198.73% | -6.06% | 105.74% | 51.84% | 36.61% |
| EPS Diluted | 963.64% | -32.30% | 145.59% | -140.12% | 35.29% |
| Normalized Diluted EPS | -166.19% | -6.06% | 105.74% | 51.84% | 36.61% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 12.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |